22 May 1997 Update of laser hyperthermic treatment for primary breast cancer: ex-vivo and in-vivo models
Author Affiliations +
Proceedings Volume 2970, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems VII; (1997); doi: 10.1117/12.275021
Event: BiOS '97, Part of Photonics West, 1997, San Jose, CA, United States
Abstract
The treatment of primary breast cancer in the last half century has progressively decreased in its disfiguring consequences while maintaining the same level of cure. Extending this philosophy beyond lumpectomy, we propose to treat small primary breast cancers by laser interstitial therapy with minimal possible cosmetic distortion. Our program to achieve that goal has made considerable progress in the preclinical instrument modification and development of physical, tissue, and live animal models. In anticipation of a clinical trial this report updates information presented in 1996.
© (1997) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
David S. Robinson, Jean-Marie A. Parel, Xochitl Gonzalez-Cirre, David B. Denham, Fabrice Manns, Peter J. Milne, Robert D. Schachner, Alan J. Herron, Jason I. Comander, Gerhard Hauptmann, "Update of laser hyperthermic treatment for primary breast cancer: ex-vivo and in-vivo models", Proc. SPIE 2970, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems VII, (22 May 1997); doi: 10.1117/12.275021; https://doi.org/10.1117/12.275021
PROCEEDINGS
4 PAGES


SHARE
KEYWORDS
Breast cancer

Animal model studies

Tumor growth modeling

Laser therapeutics

Clinical trials

Distortion

Instrument modeling

RELATED CONTENT


Back to Top